1) Igaki H, Kato H, Tachimori Y, et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothoracic Surg 20 : 1089-1094, 2001
2) Ishida K, Ando N, Yamamoto S, et al. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group(JEOG)/Japan Clinical Oncology Group trial(JCOG9516). Jpn J Clin Oncol 34 : 615-619, 2004
3) Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 : 2697-2702, 2003
4) Minsky D, Pajak F, Kelsen P, et al. INT0123(Radiation Therapy Oncology Group 94-05)phase III trial of combined-modality therapy for esophageal cancer : High-dose versus standard-dose radiation therapy. J Clin Oncol 20 : 1167-1174, 2002
5) Kato H, Udagawa H, Togo A, et al. A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group study(JCOG9708). Proc Am Soc Clin Oncol 22 : 286a(abstract 1147), 2003
6) Kato H, Tachimori Y, Muzobuchi A, et al. Cervical, mediastinal and abdominal lymph node dissection(theree-field dissection)for superficial carcinoma of thoracic esophagus. Cancer 72 : 2879-2882, 1993